William J Taylor1, Jaap Fransen1, Nicola Dalbeth1, Tuhina Neogi1, H Ralph Schumacher1, Melanie Brown1, Worawit Louthrenoo1, Janitzia Vazquez-Mellado1, Maxim Eliseev1, Geraldine McCarthy1, Lisa K Stamp1, Fernando Perez-Ruiz1, Francisca Sivera1, Hang-Korng Ea1, Martijn Gerritsen1, Carlo A Scire1, Lorenzo Cavagna1, Chingtsai Lin1, Yin-Yi Chou1, Anne-Kathrin Tausche1, Geraldo da Rocha Castelar-Pinheiro1, Matthijs Janssen1, Jiunn-Horng Chen1, Ole Slot1, Marco Cimmino1, Till Uhlig1, Tim L Jansen1. 1. From the University of Otago, Wellington; University of Auckland, Auckland; Department of Medicine, University of Otago Christchurch, Christchurch, New Zealand; Radboud University Medical Centre, Nijmegen; Amsterdam Rheumatology Immunology Center (ARC), Department of Rheumatology, Westfries Gasthuis, Hoorn; Rijnstate Hospital, Arnhem, the Netherlands; Boston University School of Medicine, Boston, Massachusetts; University of Pennsylvania, Philadelphia, Pennsylvania, USA; Division of Rheumatology, Department of Internal Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand; Servicio de Reumatología, Hospital General de México, México City, México; Nasonova Research Institute of Rheumatology of Russia, Moscow, Russia; School of Medicine and Medical Science, University College Dublin; Mater Misericordiae University Hospital, Dublin, Ireland; Rheumatology Division, Hospital Universitario Cruces and BioCruces Health Research Institute, Vizcaya; Department Reumatologia, Hospital General Universitario de Elda, Alicante, Spain; Université Paris Diderot, Sorbonne Paris Cité, UFR de Médecine; Institut national de la santé et de la recherche médicale (INSERM), UMR 1132, Hôpital Lariboisière; Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Lariboisière, Service de Rhumatologie, Centre Viggo Petersen, Pôle Appareil Locomoteur, Paris, France; Epidemiology Unit, Italian Society for Rheumatology (SIR), Milan; Division of Rheumatology, University and IRCCS Policlinico S. Matteo Foundation, Pavia; Research Laboratory and Academic Division of Clinical Rheumatology, Department of Internal Medicine, University of Genoa, Genoa, Italy; Division of Rheumatology and Immunology, Taichung Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation; Taichung Veterans' General Hospital; School of Medicine, China Medical University; Department of Internal Medicine, China Medical University Hospital, Taichung, Taiwan; Division of Rheumatology, Department of In
Abstract
OBJECTIVE: To determine the frequency of adverse events of diagnostic arthrocentesis in patients with possible gout. METHODS: Consecutive patients underwent arthrocentesis and were evaluated at 6 weeks to determine adverse events. The 95% CI were obtained by bootstrapping. RESULTS: Arthrocentesis was performed in 910 patients, and 887 (97.5%) were evaluated for adverse events. Any adverse event was observed in 12 participants (1.4%, 95% CI 0.6-2.1). There was 1 case (0.1%, 95% CI 0-0.34) of septic arthritis. CONCLUSIONS: Diagnostic arthrocentesis is associated with a low frequency of adverse events. Septic arthritis rarely occurs.
OBJECTIVE: To determine the frequency of adverse events of diagnostic arthrocentesis in patients with possible gout. METHODS: Consecutive patients underwent arthrocentesis and were evaluated at 6 weeks to determine adverse events. The 95% CI were obtained by bootstrapping. RESULTS: Arthrocentesis was performed in 910 patients, and 887 (97.5%) were evaluated for adverse events. Any adverse event was observed in 12 participants (1.4%, 95% CI 0.6-2.1). There was 1 case (0.1%, 95% CI 0-0.34) of septic arthritis. CONCLUSIONS: Diagnostic arthrocentesis is associated with a low frequency of adverse events. Septic arthritis rarely occurs.
Authors: Tej B Bhavsar; Wilmer L Sibbitt; Philip A Band; Romy J Cabacungan; Timothy S Moore; Luis C Salayandia; Roderick A Fields; Scarlett K Kettwich; Luis P Roldan; N Suzanne Emil; Monthida Fangtham; Arthur D Bankhurst Journal: Clin Rheumatol Date: 2017-09-14 Impact factor: 2.980
Authors: Yessica Zamudio-Cuevas; Gabriela Angélica Martínez-Nava; Karina Martínez-Flores; Lucio Ventura-Ríos; Janitzia Vazquez-Mellado; Pedro Rodríguez-Henríquez; Carlos Pineda; Rafael Franco-Cendejas; Carlos Alberto Lozada-Pérez; Javier Fernández-Torres Journal: Clin Rheumatol Date: 2021-02-17 Impact factor: 2.980
Authors: In Ah Choi; Ji Hyoun Kim; Yun Jong Lee; Eun Ha Kang; You Jung Ha; Kichul Shin; Jeong Seok Lee; Eunyoung Emily Lee; Jin Kyun Park; Eun Young Lee; Eun Bong Lee; Yeong Wook Song Journal: J Korean Med Sci Date: 2019-06-10 Impact factor: 2.153